Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722263 · ClinicalTrials.gov registry record · NA
Radiotherapy for Keloids
A NA study of Keloid, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04722263 is a NA study of Keloid that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 15 participants, below the 2,142-participant average among 8 other Keloid trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04722263, a NA study of Keloid, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.
Conditions Studied
Interventions
- RADIATION Radiotherapy
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04722263
The ClinicalTrials.gov registry entry for NCT04722263 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,142-participant average among 8 other Keloid trials with a reported enrollment target (99% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keloid appearing as the primary indexed condition, and to 1 intervention - of which Radiotherapy is the first listed.
NCT04722263 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04722263 about?
NCT04722263 is a clinical study titled "Radiotherapy for Keloids". The purpose of this pilot study is to evaluate the safety and efficacy of radiation therapy (RT) in the treatment of unresected keloids.
What is the current status of trial NCT04722263?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-12-01. Estimated completion is 2026-06.
What conditions does trial NCT04722263 study?
This clinical trial studies the following conditions: Keloid.
What interventions are being tested in trial NCT04722263?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT04722263?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722263 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keloid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
COMPLETED · NA
-
"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"
COMPLETED · NA
-
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
RECRUITING · Phase 2
-
Genetic Analysis of Keloids
RECRUITING
-
Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
RECRUITING
-
RAPA-Keloid Study of Keloid Regression
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.